Presentation is loading. Please wait.

Presentation is loading. Please wait.

Volume 139, Issue 2, Pages (August 2010)

Similar presentations


Presentation on theme: "Volume 139, Issue 2, Pages (August 2010)"— Presentation transcript:

1 Volume 139, Issue 2, Pages 409-417 (August 2010)
Effects of Lesogaberan on Reflux and Lower Esophageal Sphincter Function in Patients With Gastroesophageal Reflux Disease  Guy E. Boeckxstaens, Hanneke Beaumont, Veerle Mertens, Hans Denison, Magnus Ruth, John Adler, Debra G. Silberg, Daniel Sifrim  Gastroenterology  Volume 139, Issue 2, Pages (August 2010) DOI: /j.gastro Copyright © 2010 AGA Institute Terms and Conditions

2 Figure 1 Study design showing (A) randomization schedule and visits and (B) schedule of dosing, standardized meals, and pharmacodynamic and symptom assessments. Patients received lesogaberan or placebo in addition to their current proton pump inhibitor therapy. Gastroenterology  , DOI: ( /j.gastro ) Copyright © 2010 AGA Institute Terms and Conditions

3 Figure 2 Number of TLESRs with lesogaberan or placebo (A) for individual patients 0–3 hours after the standardized meal consumed 1 hour after the third dose and (B) hourly geometric means over the 4 hours after the third dose. Error bars show 95% CIs. Gastroenterology  , DOI: ( /j.gastro ) Copyright © 2010 AGA Institute Terms and Conditions

4 Figure 3 Mean LES pressure with lesogaberan and placebo during the stationary assessment 4 hours after the third treatment dose. Error bars show upper or lower extent of 95% CIs. Gastroenterology  , DOI: ( /j.gastro ) Copyright © 2010 AGA Institute Terms and Conditions

5 Figure 4 Mean number of reflux episodes with lesogaberan and placebo (A) during the stationary assessment 0–3 hours after the meal consumed 1 hour after the third dose and (B) during the ambulatory assessment 0–24 hours after the first dose. (C) Mean number of pure liquid, mixed gas/liquid, and pure gas reflux episodes with lesogaberan and placebo, during the stationary assessment 0–4 hours after the third treatment dose and during the ambulatory assessment 0–24 hours after the first dose. Error bars show 95% CIs. Gastroenterology  , DOI: ( /j.gastro ) Copyright © 2010 AGA Institute Terms and Conditions


Download ppt "Volume 139, Issue 2, Pages (August 2010)"

Similar presentations


Ads by Google